Cerebrovascular Accumulation and Increased Blood‐Brain Barrier Permeability to Circulating Alzheimer's Amyloid β Peptide in Aged Squirrel Monkey with Cerebral Amyloid Angiopathy

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Neurochemistry

• Publication date

  1998-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1471-4159.1998.70010210.xPMID 9422364
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid in the brains of aged squirrel monkeys

  2004cited by this paper
• Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta.

  1997cited by this paper
• Isoform‐Specific Effects of Apolipoproteins E2, E3, and E4 on Cerebral Capillary Sequestration and Blood‐Brain Barrier Transport of Circulating Alzheimer's Amyloid β

  1997cited by this paper
• The Pathogenesis of Senile Plaques

  1997cited by this paper
• Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide.

  1997cited by this paper
• Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier.

  1997cited by this paper
• Can blood-brain barrier play a role in the development of cerebral amyloidosis and Alzheimer's disease pathology.

  1997cited by this paper
• Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils

  1996cited by this paper
• Selective binding of soluble Abeta1-40 and Abeta1-42 to a subset of senile plaques.

  1996cited by this paper
• Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities.

  1996cited by this paper
• Intra-arterial infusion of [125I]A beta 1-40 labels amyloid deposits in the aged primate brain in vivo.

  1996cited by this paper
• Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.

  1996cited by this paper
• Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs.

  1996cited by this paper
• Amyloid ox–tox transducers

  1996cited by this paper
• Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils.

  1996cited by this paper
• The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease.

  1996cited by this paper
• RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

  1996cited by this paper
• Alzheimer's disease. Amyloid ox-tox transducers.

  1996cited by this paper
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

  1996cited by this paper
• In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics.

  1996cited by this paper
• Fate of Cerebrospinal Fluid‐Borne Amyloid β‐Peptide: Rapid Clearance into Blood and Appreciable Accumulation by Cerebral Arteries

  1996cited by this paper
• Two conformational states of amyloid β-peptide: implications for the pathogenesis of Alzheimer's disease

  1995cited by this paper
• Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.

  1995cited by this paper
• Cerebrovascular Permeability to Peptides: Manipulations of Transport Systems at the Blood-Brain Barrier

  1995cited by this paper
• Passage of human amyloid β-protein 1–40 across the murine blood-brain barrier

  1994cited by this paper
• High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy.

  1994cited by this paper
• Passage of human amyloid beta-protein 1-40 across the murine blood-brain barrier.

  1994cited by this paper
• Unifying features of systemic and cerebral amyloidosis

  1994cited by this paper
• Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

  1993cited by this paper
• Characterization of beta-amyloid peptide from human cerebrospinal fluid.

  1993cited by this paper
• Blood-brain barrier transport of circulating Alzheimer's amyloid beta.

  1993cited by this paper
• Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid.

  1992cited by this paper
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

  1992cited by this paper
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

  1992cited by this paper
• Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

  1990cited by this paper
• Capillary Depletion Method for Quantification of Blood–Brain Barrier Transport of Circulating Peptides and Plasma Proteins

  1990cited by this paper
• Cerebral amyloid angiopathy. A critical review.

  1987cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Intra-arterial infusion.

  1961cited by this paper

• Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-β Peptides and Insulin

  2021cites this paper
• Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer's pathology: Insights and therapeutic approaches from periphery.

  2021influential citation
• Single-cell RNA sequencing identifies senescent cerebromicrovascular endothelial cells in the aged mouse brain

  2020cites this paper
• Animal Models of Pathological Aging

  2018cites this paper
• Role of Blood-Brain Barrier in Alzheimer’s Disease

  2018cites this paper
• Does the Genetic Feature of the Chinese Tree Shrew (Tupaia belangeri chinensis) Support Its Potential as a Viable Model for Alzheimer’s Disease Research?

  2018cites this paper
• Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: 2. Relationship to amyloid β immunotherapy

  2018cites this paper
• Age-dependent Disturbances of Neuronal and Glial Protein Expression Profiles in Areas of Secondary Neurodegeneration Post-stroke.

  2018cites this paper
• Immunoreactivity of Anti-AβP-42 Specific Antibody with Toxic Chemicals and Food Antigens

  2018cites this paper
• Alteration of Vascular Endothelial Cadherin in Alzheimer’s Disease Patient and Mouse Model

  2018cites this paper
• Guidance on the risk assessment of substances present in food intended for infants below 16 weeks of age

  2017cites this paper
• Peripheral complement interactions with amyloid b peptides in Alzheimer ’ s disease : Erythrocyte clearance of amyloid b peptides

  2017cites this paper
• Peripheral complement interactions with amyloid β peptide: Erythrocyte clearance mechanisms

  2017cites this paper
• Peripheral complement interactions with amyloid b peptide in Alzheimer ’ s disease : 2 . Relationship to A b immunotherapy

  2017cites this paper
• Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer’s disease

  2017cites this paper
• A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain

  2017cites this paper
• A Surgical Method to Improve the Homeostasis of CSF for the Treatment of Alzheimer’s Disease

  2016cites this paper
• Imaging of Neurotransmitter Systems in Dementia

  2016cites this paper
• Pathophysiological Links Among Hypertension and Alzheimer’s Disease

  2016cites this paper
• Restoration of Cerebral and Systemic Microvascular Architecture in APP/PS1 Transgenic Mice Following Treatment with Liraglutide™

  2015cites this paper
• A mathematical model of the impact of novel treatments on the Aβ burden in the Alzheimer’s brain, CSF and plasma

  2015cites this paper
• Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease

  2014cites this paper
• Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-β ex vivo activation of peripheral chemo-cytokines from Alzheimer's disease subjects: exploring the cholinergic anti-inflammatory pathway.

  2014cites this paper
• Cystatin C and Alzheimer's Disease

  2014cites this paper
• The blood-brain barrier: Structure, function and therapeutic approaches to cross it

  2014cites this paper
• Membrane-Spanning 4-Domains Subfamily A, MS4A Cluster

  2013cites this paper
• Insulin-like growth factor-1 in CNS and cerebrovascular aging

  2013cites this paper
• Blood-brain barrier transport of amyloid beta peptides in efflux pump knock-out animals evaluated by in vivo optical imaging

  2013cites this paper
• Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease

  2013cites this paper
• Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-β proteins in the cerebral vasculature.

  2013cites this paper
• A Lipoprotein Receptor Cluster IV Mutant Preferentially Binds Amyloid-β and Regulates Its Clearance from the Mouse Brain*

  2013cites this paper
• Adjusting the compass: new insights into the role of angiogenesis in Alzheimer’s disease

  2013cites this paper
• Enhanced Proteolytic Clearance of Plasma Aβ by Peripherally Administered Neprilysin Does Not Result in Reduced Levels of Brain Aβ in Mice

  2013cites this paper
• In Vitro Investigation of Amyloid-β Hepatobiliary Disposition in Sandwich-Cultured Primary Rat Hepatocytes

  2013cites this paper
• Hereditary and sporadic beta-amyloidoses.

  2013cites this paper
• Human Serum Albumin Can Regulate Amyloid-β Peptide Fiber Growth in the Brain Interstitium

  2012cites this paper
• Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation.

  2012cites this paper
• Blood–spinal cord barrier pericyte reductions contribute to increased capillary permeability

  2012cites this paper
• The role of inflammatory processes in Alzheimer’s disease

  2012cites this paper
• The Imbalance of Vascular Molecules in Alzheimer's Disease

  2012cites this paper
• Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.

  2012influential citation
• The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery.

  2012cites this paper
• Ginsenoside Rg1 attenuates tau phosphorylation in SK-N-SH induced by Aβ-stimulated THP-1 supernatant and the involvement of p38 pathway activation.

  2012cites this paper
• IMMUNE MECHANISMS ASSOCIATED TO NEUROINFLAMMATION IN ALZHEIMER'S DISEASE

  2012cites this paper
• Invited Review Cerebrovascular amyloidosis: Experimental analysis in vitro and in vivo

  2011cites this paper
• Highlights Perspectives from an Immunologist and a Neuroscientist on inflammatory versus neurodegenerative basis of multiple sclerosis and Alzheimer ’ s disease

  2011cites this paper
• 'Alzheimer-like' pathology in a murine model of arterial hypertension.

  2011cites this paper
• From the liver to the blood–brain barrier: An interconnected system regulating brain amyloid‐β levels

  2011cites this paper
• Impaired Lipoprotein Receptor-Mediated Peripheral Binding of Plasma Amyloid-β is an Early Biomarker for Mild Cognitive Impairment Preceding Alzheimer's Disease

  2011influential citation
• The functions of the amyloid precursor protein gene.

  2011cites this paper
• Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

  2011cites this paper
• ERK pathway activation is required for amyloid-β(1-40)(-)induced neurotoxicity of THP-1 human monocytes towards SK-N-SH neuroblastoma.

  2011cites this paper
• The development of small primate models for aging research.

  2011cites this paper
• Cerebral amyloid angiopathy in the elderly

  2011cites this paper
• Cerebral Amyloid Angiopathy: A Systematic Review

  2011cites this paper
• Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging.

  2010cites this paper
• Low‐density lipoprotein receptor‐related protein‐1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β‐peptide elimination from the brain

  2010cites this paper
• Cerebral Vascular Dysfunction in Alzheimer's Disease

  2010cites this paper
• The Role of the Cell Surface LRP and Soluble LRP in Blood-Brain Barrier A β Clearance in Alzheimer’s Disease

  2010cites this paper
• Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.

  2009cites this paper
• Cerebral amyloid angiopathy: a common cause of cerebral hemorrhage.

  2009cites this paper
• Development of vaccination approaches for the treatment of neurological diseases

  2009cites this paper
• Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests

  2009cites this paper
• Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies

  2009influential citation
• Estudi dels mecanismes moleculars implicats en el dany vascular induït per l'activitat catalítica de la SSAO en el context de l'angiopatia cerebral amiloide associada a la demència tipus Alzheimer

  2009cites this paper
• Clearance of amyloid-β peptide across the blood-brain barrier: Implication for therapies in Alzheimer’s disease

  2009cites this paper
• Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier

  2008cites this paper
• Do red blood cell-beta-amyloid interactions alter oxygen delivery in Alzheimer's disease?

  2008cites this paper
• Functional role of lipoprotein receptors in Alzheimer's disease.

  2008cites this paper
• Aging cebidae.

  2008cites this paper
• The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.

  2008cites this paper
• Insulin Facilitates the Hepatic Clearance of Plasma Amyloid β-Peptide (1–40) by Intracellular Translocation of Low-Density Lipoprotein Receptor-Related Protein 1 (LRP-1) to the Plasma Membrane in Hepatocytes

  2007cites this paper
• Cerebral beta-amyloid angiopathy in aged squirrel monkeys.

  2007cites this paper
• Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.

  2007cites this paper
• Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System

  2007cites this paper
• Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology.

  2007cites this paper
• Mechanism of Cerebral β‐Amyloid Angiopathy: Murine and Cellular Models

  2006cites this paper
• Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.

  2006cites this paper
• Major Involvement of Low-Density Lipoprotein Receptor-Related Protein 1 in the Clearance of Plasma Free Amyloid β-Peptide by the Liver

  2006cites this paper
• A View on Early Diagnosis of Dementias from Neuropathology

  2006cites this paper
• Cerebral ß-amyloid angiopathy in aged squirrel monkeys

  2006cites this paper
• Red cell interactions with amyloid-β1-40 fibrils in a murine model

  2005cites this paper
• Red cell interactions with amyloid-beta(1-40) fibrils in a murine model.

  2005cites this paper
• Alzheimer’s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy

  2005cites this paper
• Amyloid Beta and the Cerebral Vasculature

  2005cites this paper
• Novel ventriculoperitoneal shunt in Alzheimer´s disease cerebrospinal fluid biomarkers

  2004cites this paper
• Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology—a pilot study

  2004cites this paper
• Amyloid β peptide 1–42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology

  2004cites this paper
• Amyloid β peptide 1–42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology

  2004cites this paper
• Links Between the Pathology of Alzheimer's Disease and Vascular Dementia

  2004cites this paper
• Cerebral Amyloid Angiopathy: New Insights from Transgenic Mice

  2004cites this paper
• Toward modeling hemorrhagic and encephalitic complications of Alzheimer amyloid-beta vaccination in nonhuman primates.

  2004cites this paper
• Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice.

  2004cites this paper
• Neutral sphingomyelinase activation in endothelial and glial cell death induced by amyloid beta-peptide.

  2004cites this paper
• Unifying concept for Alzheimer's disease, vascular dementia and normal pressure hydrocephalus - a hypothesis.

  2004cites this paper
• Influence of beta-amyloid fibrils on the interactions between red blood cells and endothelial cells

  2004cites this paper
• RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

  2003cites this paper
• Aβ, aging, and Alzheimer's disease: A tale, models, and hypotheses

  2003cites this paper
• Pathogenesis of cerebral amyloid angiopathy.

  2003cites this paper
• Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis.

  2003cites this paper